Skip to main content
. Author manuscript; available in PMC: 2014 Aug 6.
Published in final edited form as: Pharm Res. 2009 May 5;26(7):1752–1763. doi: 10.1007/s11095-009-9886-2

Fig. 8.

Fig. 8

Dissolution profiles of paclitaxel in PBS (pH 7.4) from A, B paclitaxel powder as received and two different nanoparticle formulations (NP), nanoparticle agglomerate formulations (NA) and F1 combination. C Dissolution profiles of cisplatin from cisplatin powder as received and from F1 combination.